Hartree Partners LP Takes $958,000 Position in Aspen Aerogels, Inc. $ASPN

Key Points

• Hartree Partners LP has acquired a new stake in Aspen Aerogels, purchasing 150,000 shares valued at approximately $958,000.
• Aspen Aerogels reported a negative EPS of ($0.04) for the last quarter, exceeding analysts' expectations, but a revenue drop of 33.8% compared to the previous year.
• Institutional investors now hold 97.64% of Aspen Aerogels, with multiple hedge funds significantly increasing their positions in the company during the 1st quarter.

Hartree Partners LP acquired a new position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 150,000 shares of the construction company's stock, valued at approximately $958,000. Hartree Partners LP owned approximately 0.18% of Aspen Aerogels as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Allspring Global Investments Holdings LLC raised its stake in Aspen Aerogels by 96.2% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 299,311 shares of the construction company's stock worth $1,901,000 after purchasing an additional 146,794 shares in the last quarter. Janney Montgomery Scott LLC acquired a new position in shares of Aspen Aerogels in the 1st quarter valued at approximately $681,000. Concurrent Investment Advisors LLC acquired a new position in shares of Aspen Aerogels in the 1st quarter valued at approximately $109,000. Barclays PLC raised its position in shares of Aspen Aerogels by 16.8% in the 4th quarter. Barclays PLC now owns 107,764 shares of the construction company's stock valued at $1,280,000 after buying an additional 15,462 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its position in shares of Aspen Aerogels by 645.4% in the 4th quarter. BNP Paribas Financial Markets now owns 135,584 shares of the construction company's stock valued at $1,611,000 after buying an additional 117,395 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Stock Down 1.8%

Shares of Aspen Aerogels stock traded down $0.13 during trading on Thursday, reaching $6.89. 531,820 shares of the company traded hands, compared to its average volume of 2,012,042. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $30.24. The company has a 50 day moving average price of $6.97 and a 200-day moving average price of $6.70. The firm has a market capitalization of $567.71 million, a PE ratio of -1.81 and a beta of 2.73.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The company had revenue of $78.02 million for the quarter, compared to the consensus estimate of $72.53 million. During the same quarter in the previous year, the company earned $0.21 EPS. Aspen Aerogels's quarterly revenue was down 33.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, equities research analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Insider Activity at Aspen Aerogels

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the sale, the chief accounting officer owned 19,879 shares in the company, valued at $145,315.49. This represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 4.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on ASPN shares. Barclays cut shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and upped their price objective for the stock from $7.00 to $16.00 in a research report on Monday, August 11th. Oppenheimer cut shares of Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. Finally, Canaccord Genuity Group lowered their price objective on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $19.50.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.